Secondary care : Please note that though there may be drugs listed with a Formulary status in this section, you should refer to the Acute Trust's antibiotic policy found here as there are some restrictions, which require microbiology approval before they can be supplied by Pharmacy.
Primary Care - refer to local guidance for more advice
Treatment is recommended within Public Health England (PHE) guidance on the use of antiviral agents for the treatment and prophylaxis of seasonal influenza.
For the treatment of critically ill adults and children having a life-threatening condition due to suspected or confirmed pandemic A(H1N1)v infection or infection due to seasonal influenza A or B virus and answering to the following criteria:
· Patients not responding to either oral or inhaled authorised antiviral medicinal products or
· Patients for whom drug delivery by a route other than IV (e.g. oral oseltamivir or inhaled zanamivir) is not expected to be dependable or is not feasible, or
· Patients infected with documented oseltamivir-resistant influenza virus and not suitable for therapy with inhaled zanamivir.
Non Formulary Items
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Secondary care only, not to be prescribed in primary care.
Specialist initiation with shared care guidance
Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline
Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline
Considered suitable for primary care prescribing following specialist initiation/recommendation.
Considered appropriate for prescribing in both secondary and primary care.
Suitable for initiation in primary care.